1st Quarter - Report
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Promoted life sciences community and communicated economic and health benefits of the industry. S.344: Hatch-Waxman Integrity Act of 2019. H.R 269: Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
H.R. 2207: Protect Medical Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education about CMS rule changing protections for beneficiaries in Medicare Part D six protected classes. Regulatory and legislative proposals in the Administrations Blueprint.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.